Tacrolimus effect on rosacea

被引：58

作者：

Bamford, JTM

Elliott, BA

Haller, IV

机构：

[1] St Marys Duluth Clin Hlth Syst, Dermatol Sect, Duluth, MN 55805 USA

[2] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA

[3] St Marys Duluth Clin Hlth Syst, Div Educ & Res, Duluth, MN 55805 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2004年 / 50卷 / 01期

关键词：

D O I：

10.1016/S0190-9622(03)02157-1

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Twenty-four patients with erythrotelangiectatic or papulopustular rosacea were treated with 0.1% tacrolimus topical ointment in a 12-week open-label trial. Erythema was significantly improved in both rosacea subtypes (P <.05). There was no decrease in the number of papulopustular lesions. Side effects were consistent with those on the tacrolimus topical ointment labeling. (J Am Acad Dermatol 2004;50:107-8.)

引用

页码：107 / 108

页数：2

共 8 条

[1] Applications of tacrolimus for the treatment of skin disorders [J].